drugset / Trial / NCT07232563

Exploratory Study of Intranasal Administration of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Ischemic Stroke

NCT07232563 ↗

Phase 1 Not yet recruiting 9 enrolled Zhujiang Hospital
NaSingle-groupOpen-labelTreatment

Summary

Evaluation of the Safety and Preliminary Efficacy of Intranasal Administration of Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles (hUC-MSC-sEV-001) in Patients for Ischemic Stroke

Timeline

Start
2025-12-01
Primary completion
2027-06-01
Completion
2027-11-07

Drugs

EvaluationDrugModalityDoseRoute
Subject hUC-MSC-sEV-001 Other / unclassified 1e+11 unknown Intranasal

Indications